Press release
Until ROI takes the Pharmacovigilance 2010 by Virtue Insight Global through LIVE Blogging
The Pharmacovigilance 2010 a first of its kinds congruence of the leaders from Pharmacovigilance domain in India, recently concluded in Mumbai which was well attended by the thought leaders from and had the top strata of the industry participating and discussing the issues and opportunities within the Pharmaceutical industry.The conference touched upon the various aspects of the Pharma industry and how the Pharmacovigilance as a niche is growing and expanding towards new arenas. The conference had participants discuss business opportunities to critical issues as drug safety and Risk analysis.
Until ROI covered the conference LIVE on the Internet through Blogs and twitter creating content for the Global audience. Speaking on the success, Paritosh Sharma, Founder, Until ROI, said “We are happy to be one of the very few companies globally, supporting thought leaders in the Pharmacovigilance domain establish their thought leadership, backed with our strong research and content based marketing efforts”.
The Pharmacovigilance 2010 was the perfect platform for engaging discussions and provided an open platform for delegate(s) to network with the relevant people from the domain. Commenting upon the success of the conference Ms. Sarika Sareen, Head Sales, Virtue Insight, remarked “The Until ROI team has been pro-active in suggesting us, innovative methods of creating success with our conferences. We see great value in leveraging the web for our conferences, with increased visibility for our delegate(s) and Sponsors and also providing a networking opportunity post conference for our delegate(s)”.
Virtue Insight equips business professionals around the world with the latest indepth industry knowledge and provides networking opportunities in the telecom, infrastructure and pharmaceutical industry. Our aim is to provide a platform to share knowledge and insights and provide our event attendees to network effectively and deliver maximum ROI by make new business alliances. We strive to produce high quality conferences which include the latest topics which are delivered by world class leaders of the industry.
Our motto is to offer our customers the expertise and connections for a profitable business. Our events encompass an optimum chance to gain maximum value in terms of networking and an opportunity to sponsor and exhibit to attract new business alliances.
About Until ROI:
Until ROI is an end to end marketing technology and solutions company. We are an end to end marketing solutions company, leveraging the various Media, to help our clients create the right outreach to the relevant target segment.
We help our clients create solid marketing strategies, supported by quality content, influenced by the positioning, customer perception and the media.
Supporting marketing with strong metrics and statistics, we help small businesses and SME's with custom business applications, leveraging the open source technology.
Virtue Insight,
Chennai – 600 087
India
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Until ROI takes the Pharmacovigilance 2010 by Virtue Insight Global through LIVE Blogging here
News-ID: 120774 • Views: …
More Releases from Virtue Insight

2nd Annual IoT Summit 2016
2nd Annual IoT Summit 2016
27th July 2016, The Lalit Ashok Hotel, Bangalore, India
“Unleashing a bold era of IoT innovation”
KEY THEMES DISCUSSED:-
-Market analysis - Will 2016 be the connected living era?
-Monetizing the machine: Business models for the IoT
-The future of IoT development
-Platforms, Smart meters, Gateways & Hubs: Creating a seamless connected home ecosystem
-Leveraging the connected home to drive growth
-Wearable technologies – An integral part of the IoE
-Designing for the next…

2nd Annual Pharma Pricing, Reimbrusement & Market Access 2016
2nd Annual Pharma Pricing, Reimbursement & Market Access 2016
08th and 09th June 2016, Pestana Chelsea Bridge Hotel, London UK
“Critical guide for successfully identifying your pricing, reimbursement and market access strategies”
KEY THEMES DISCUSSED IN THIS CONFERENCE:-
-Preparing your best market access strategy
-EU and US policy challenges for market access: Stepping ahead
-Unrivalled opportunity to expose and address the market access challenges facing the industry
-Current & future - Challenges & opportunities in pharma pricing,…

7th Annual Clinical Trials Summit 2016
7th Annual Clinical Trials Summit 2016
24th May 2016, The Lalit Hotel, Mumbai, India
“A critical guide for successfully conducting clinical trials”
KEY THEMES DISCUSSED IN THIS CONFERENCE:-
-Insights, Implications, Impact and Implementation of risk management in trial conduct
-Tracking returns, Reconciliation & Destruction to manage costs
-Reduce significant costs through successful embedding of modulation and simulation in the clinical supply chain
-Underlining the benefits and implications of drug pooling in the clinical supply…
More Releases for Pharma
Miglitol Market Size, Share and Forecast By Key Players-Weiao Pharma, Zhejiang M …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Miglitol market is anticipated to grow at a compound annual growth rate (CAGR) of 11.49% between 2024 and 2031. The market is expected to grow to USD 22.32 Billion by 2024. The valuation is expected to reach USD 47.79 Billion by 2031.
The Miglitol market is experiencing significant growth due to the rising prevalence of diabetes and the increasing awareness of the…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasing…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. As…
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the…
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis.
Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382
The Indomethacin Global Market Research Report provides close monitoring…
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 …
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024.
Global Roxatidine Market overview:
Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the…